ImmuneWatch receives Horizon Europe funding in a new innovative European partnership to tackle hurdles in malaria vaccine development
With cutting-edge technologies and an unwavering commitment, the EU-funded CAPTIVATE project has the mission to create a next-generation malaria vaccine that targets multiple stages of the deadliest malaria parasite, P. falciparum. Malaria remains a significant global health issue, with approximately 247 million cases and 619,000 fatalities reported in 2021. It primarily affects the most susceptible […]